These data demonstrated that PXN-AS1 knockdown could restrain the growth of CML IR cells and rescue the cell cycle disorder of CML IR cells via suppressing the Cyclin D/CDK4-CDK6 complex and mTOR signaling pathway in vitro. Here, PXN is linked to chronic myelogenous leukemia, BCR-ABL1 positive.